Skip to content

Clinical trials

Phase 1/2 Lymphoma, B-Cell, Marginal Zone trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1/2 Country / region: United States Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20033
20042
20057
20062
20072
20084
20092
20103
20114
20122
20133
20145
20151
20161
20177
20183
20192
20202
20214
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated14
Active, not recruiting6
Recruiting6
Withdrawn4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Fred Hutchinson Cancer Center6
Mayo Clinic5
Northwestern University3
Garden State Cancer Center at the Center for Molecular Medicine and Immunology2
Genmab2
M.D. Anderson Cancer Center2
Masonic Cancer Center, University of Minnesota2
Memorial Sloan Kettering Cancer Center2
OHSU Knight Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone78
Lymphoma, Follicular75
Lymphoma, Mantle-Cell65
Leukemia, Lymphocytic, Chronic, B-Cell63
Lymphoma, Non-Hodgkin54
Lymphoma, Large B-Cell, Diffuse50
Lymphoma37
Burkitt Lymphoma36
Waldenstrom Macroglobulinemia35
Hodgkin Disease29

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.